Sleep has become a battleground for technology firms, insurers and health providers, with significant money riding on what happens overnight. Once treated as a personal habit, sleep now features in ...
Sanofi has secured regulatory approval in China for two innovative medicines, Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome. The approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback